Guardant Health

Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, extensive datasets, and advanced analytics. The company's vision has always been to develop products for the early detection of cancer. Initially, the company created Guardant360, a testing service that aids patients with advanced cancer, addressing an urgent unmet medical need. Oncologists worldwide have utilized Guardant360 for patients up to 35,000 times, making it one of the most widely used comprehensive liquid biopsies. Meanwhile, Guardant Health and SoftBank announced the formation of a new joint venture to expand the commercialization of Guardant Health’s industry-leading liquid biopsy technology in Asia, the Middle East, and Africa. The key to overcoming cancer lies in unprecedented access to its molecular information at all stages of the disease. We are developing solutions through tests that only require a blood sample.